Nuvectis Pharma, Inc.
Nuvectis Pharma, Inc. scores highest on Nitro (69) and lowest on Price (1). Its PosiPenta is 42.37 out of 100, around the middle of similar companies.
On the Penta Grid this week, Nuvectis Pharma, Inc. is Grid #457 of 837 in the Healthcare sector in United States, and Grid #2,657 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Nuvectis Pharma, Inc. | 42.37 | 1 | 42 | 69 | 51 | 49 |
| Prime Medicine, Inc. | 39.49 | 48 | 41 | 52 | 8 | 49 |
| Immix Biopharma, Inc. | 51.43 | 22 | 39 | 59 | 69 | 68 |
| Achieve Life Sciences, Inc. | 34.91 | 0 | 50 | 78 | 14 | 33 |
| Aura Biosciences, Inc. | 45.05 | 29 | 26 | 61 | 52 | 57 |
| OmniAb, Inc. | 55.46 | 24 | 50 | 88 | 61 | 54 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -14.20 |
| P/B ratio | 66.86 |
EEarnings
| Trailing EPS | ₹-124.08 |
| Forward EPS | ₹-90.93 |
NNitro
| Price | 1761.70 |
| 52-week high | 2772.78 |
| 52-week low | 525.67 |
| Fall from 52-week high | 36.5% |
TTorque
| Return on equity (ROE) | -214.58% |
| Debt-to-equity | 0.00 |
AAnchor
| Beta (price swings) | -0.24 |
| Market cap | ₹5,750 Cr |
| Insider holding | 34.43% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Nuvectis Pharma, Inc.'s PosiPenta score?
Nuvectis Pharma, Inc.'s PosiPenta is 42.37 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Nuvectis Pharma, Inc. stand on the Penta Grid?
On the Penta Grid this week, Nuvectis Pharma, Inc. is Grid #457 of 837 in the Healthcare sector in United States, and Grid #2,657 of 4,000 in United States.
Which PosiPenta pillar is strongest for Nuvectis Pharma, Inc.?
Nitro (momentum), with a score of 69 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for Nuvectis Pharma, Inc.?
Price (valuation), with a score of 1 out of 100: much weaker than most similar companies.
Has Nuvectis Pharma, Inc.'s PosiPenta changed since last week?
Yes, it rose 3.66 points, from 38.71 to 42.37.
PositoAI is for research and education only and is not investment advice.